2Fujimoto J, Kaneda Y. Reversing liver cirrhosis: impact of genetherapy for liver cirrhosis. Gene Ther, 1999,6:305-306.
3George J, Roulot D, Koteliansky VE, et al. In vivo inhibition ofrat stellate cell activation by soluble transforming growth factor betatype Ⅱ receptor:a potential new therapy for hepatic fibrosis. ProcNad Acad Sci USA, 1999,96:12719-12724.
4George J, Wang SS, Scvcsik AM, et al. Transforming growth factor-beta initiates wound repair in rat liver through induction of the EⅢ A-fibronectin splice isoform. Am J Pathol, 2000, 156:115-124.
5Qi Z, Atsuchi N, Ooshima A, et al. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA, 1999,96:2345-2349.
6Nakamura T, Sakata R, Ueno T, et al. Inhibition of transforminggrowth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.Hepatology, 2000,32: 247-255.
7Ueno H, Sakamoto T, Nakamura T, et al. A soluble transforminggrowth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Geno Ther, 2000,11: 33-42.
8Nakamura T, Sakata R, Ueno T, et al. Inhibition of transforminggrowth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.Hepatology, 2000,32: 247-255.
9Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone, 1999,25: 91-93.
10Dooley S, Streckert M, Delvoux B, et al. Expression of Smadsduring in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun,2001,283:554-562.
1Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with stractan. Anal Biolchem, 1987 ,161:207-218.
2Reeves HL, Friedman SL. Activation of hepatic stellate cellsa key issue in liver fibrosis. Front Biosci, 2002,7:D808-D826.
3Park PH, Nan JX, Park EJ, et al. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacol Toxicol, 2000,87: 261-268.
4Gressner AM, Weiskirchen R, Breitkopf K, et al. Roles of TGF-beta in hepatic fibrosis. Front Biosci, 2002, 7: D793-D807.
5Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science, 2002, 296:1646-1647.
6Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGFbeta- inducible antagonist of TGF-beta signal-ling. Nature,1997, 389:631-635.
7Dooley S, Streckert M, Delvoux B, et al. Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun,2001,283: 554-562.
8Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology, 2003,125:178-191.
9Isono M, Soda M, Inoue A, et al. Reverse transformation of hepatic myofibroblast-like cells by TGFbetal/LAP. Biochem Biophys Res Commun, 2003, 311:959-965.
